Brief: Biomed Lublin Decides To Issue Shares To Finance Strategic Projects

Synthaverse SA

29/11/2022 07:43

Nov 29 (Reuters) - Biomed Lublin SA  BML.WA :
    * SAID ON MONDAY THAT IT HAS DECIDED TO ISSUE NEW SHARES TO
RAISE
FUNDS FOR COMPANY'S STRATEGIC PROJECTS
    * THE COMPANY HAS SIGNED INVESTMENT DEAL WITH IPOPEMA
SECURITIES
REGARDING SHARES ISSUE
    * IPOPEMA SECURITIES OR ENTITY CHOSEN BY IPOPEMA WILL SELL
UP TO 5
MILLION COMPANY'S SHARES TO INVESTORS ACQUIRED IN BOOK BUILDING
PROCESS
    * THE SHARES WILL BE BORROWED FROM SELECTED INVESTORS
    * AFTER THE BOOK BUILDING PROCESS, COMPANY WILL ISSUE NEW
SHARES
IN THE SAME AMOUNT AS SHARES SOLD FOR THE ISSUE PRICE REFLECTED
IN THE BOOK BUILDING PROCESS
    * THE ISSUED SHARES WILL BE ACQUIRED BY IPOPEMA OR ENTITY
CHOSEN
BY IPOPEMA AND THEN RETURNED TO THE SHARE LENDERS
    * THE FUNDS OBTAINED FROM THE SALE OF SHARES WILL BE FULLY
TRANSFERRED TO THE COMPANY FOR PAYMENT OF SHARES UNDER THE NEW
SHARE ISSUE
    * THE TOTAL COSTS OF RAISING CAPITAL THROUGH THE NEW SHARE
ISSUE
ARE ESTIMATED AT THE AMOUNT CORRESPONDING TO ABOUT 3.5% OF THE
TOTAL ISSUE PRICE OF THE SHARES UNDER THE NEW SHARE ISSUE

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM4sZjxga
 Further company coverage:  BML.WA  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))